SARS-CoV-2 genomic variations associated with mortality rate of COVID-19

Y Toyoshima, K Nemoto, S Matsumoto… - Journal of human …, 2020 - nature.com
The coronavirus disease 2019 (COVID-19) outbreak, caused by SARS-CoV-2, has rapidly
expanded to a global pandemic. However, numbers of infected cases, deaths, and mortality …

Bioinformatic prediction of potential T cell epitopes for SARS-Cov-2

K Kiyotani, Y Toyoshima, K Nemoto… - Journal of human …, 2020 - nature.com
To control and prevent the current COVID-19 pandemic, the development of novel vaccines
is an emergent issue. In addition, we need to develop tools that can measure/monitor T-cell …

Lack of interleukin‐6 in the tumor microenvironment augments type‐1 immunity and increases the efficacy of cancer immunotherapy

Y Ohno, Y Toyoshima, H Yurino, N Monma… - Cancer …, 2017 - Wiley Online Library
Conquering immunosuppression in tumor microenvironments is crucial for effective cancer
immunotherapy. It is well known that interleukin ( IL )‐6, a pleiotropic cytokine, is produced in …

Interleukin‐6/STAT 3 signaling as a promising target to improve the efficacy of cancer immunotherapy

H Kitamura, Y Ohno, Y Toyoshima, J Ohtake… - Cancer …, 2017 - Wiley Online Library
Overcoming the immunosuppressive state in tumor microenvironments is a critical issue for
improving the efficacy of cancer immunotherapy. Interleukin ( IL )‐6, a pleiotropic cytokine, is …

IFN‐α/β‐mediated NK2R expression is related to the malignancy of colon cancer cells

H Xiang, Y Toyoshima, W Shen, X Wang… - Cancer …, 2022 - Wiley Online Library
Neurokinin 2 receptor (NK2R), a G protein‐coupled receptor for neurokinin A (NKA), a
tachykinin family member, regulates various physiological functions including pain response, …

IL6 modulates the immune status of the tumor microenvironment to facilitate metastatic colonization of colorectal cancer cells

Y Toyoshima, H Kitamura, H Xiang, Y Ohno… - Cancer immunology …, 2019 - AACR
It is unknown as to how liver metastases are correlated with host immune status in colorectal
cancer. In this study, we found that IL6, a proinflammatory cytokine produced in tumor-…

[HTML][HTML] Personalized immunotherapy in cancer precision medicine

K Kiyotani, Y Toyoshima… - Cancer Biology & Medicine, 2021 - ncbi.nlm.nih.gov
With the significant advances in cancer genomics using next-generation sequencing
technologies, genomic and molecular profiling-based precision medicine is used as a part of …

Immunogenomics in personalized cancer treatments

K Kiyotani, Y Toyoshima, Y Nakamura - Journal of Human Genetics, 2021 - nature.com
Recent advances in next-generation sequencing technologies have led to significant
improvements in cancer genomic research and cancer treatment. Through the use of …

Arginase-1 inhibition reduces migration ability and metastatic colonization of colon cancer cells

X Wang, H Xiang, Y Toyoshima, W Shen, S Shichi… - Cancer & …, 2023 - Springer
Background Arginase-1 (ARG1), a urea cycle-related enzyme, catalyzes the hydrolysis of
arginine to urea and ornithine, which regulates the proliferation, differentiation, and function of …

Differentiation of neural cells in the fetal cerebral cortex of cynomolgus monkeys (Macaca fascicularis)

Y Toyoshima, S Sekiguchi, T Negishi… - Comparative …, 2012 - ingentaconnect.com
Proliferation and programmed cell death are important in the formation of morphologic
structures and functional activity during CNS development. We used immunohistochemical and …